Serial FLAIR imaging after Gd-DTPA contrast: Pitfalls in stroke trial magnetic resonance imaging

Stroke

Volumn 34, Issue 3, 2003, Pages 797-798

  Rumpel, Helmut ^a   Chan, Ling Ling ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Contrast media; Magnetic resonance imaging; Stroke, acute; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; GADOLINIUM PENTETATE; PLACEBO;

AGED; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; CEREBRAL ARTERY DISEASE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; FIBRINOLYTIC THERAPY; FLUID ATTENUATED INVERSION RECOVERY; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

ACUTE DISEASE; AGED; ARTIFACTS; BRAIN; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL TRIALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC CLEARANCE RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037337765     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000056528.05390.58     Document Type: Article

References (4)

1. Warach S. Magnetic Resonance imaging in stroke trials. In: Chan PH, ed. Cerebrovascular Disease. Boston, Mass: Cambridge University Press; 2002:339-352.
2. Yamada N, Imakita S, Sakuma T. Value of diffusion-weighted imaging and apparent diffusion coefficient in recent cerebral infarctions: a correlative study with contrast-enhanced T1-weighted imaging. AJNR Am J Neuroradiol. 1999;20:193-198.
3. Magnevist [package insert]. Wayne, NJ: Berlex Laboratories; 2000.
4. Essig M, Bock M. Contrast optimization of fluid-attenuated inversionrecovery (FLAIR) MR imaging in patients with high CSF blood or protein content. Magn Reson Med. 2000;43:764-767.